Global Biosimilars Market 2025-2029

Description

List of Tables

The biosimilars market is forecasted to grow by USD 117678.1 million during 2024-2029, accelerating at a CAGR of 34.2% during the forecast period. The report on the biosimilars market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by price advantage of biosimilars over biologics, patent expiry of major biologics, and government initiatives to increase use of biosimilar medicines.

Market Scope
Base Year	2025
End Year	2029
Series Year	2025-2029
Growth Momentum	Accelerate
YOY 2025	25.6%
CAGR	34.2%
Incremental Value	$117678.1 mn

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.

Technavio's biosimilars market is segmented as below:

By Product Type

Monoclonal antibodies
Insulin
Human growth hormone
Others

By Application

Oncology and hematology
Endocrinology
Immunology
Nephrology

By Manufacturing Type

In-house manufacturing
Contract manufacturing

By Geographical Landscape

Europe
North America
Asia
Rest of World (ROW)

This study identifies the willingness to switch to biosimilars as one of the prime reasons driving the biosimilars market growth during the next few years. Also, therapeutic interchangeability regulations for biosimilars across countries and patent dance will lead to sizable demand in the market.

The report on the biosimilars market covers the following areas:

Biosimilars Market sizing
Biosimilars Market forecast
Biosimilars Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading biosimilars market vendors that include AbbVie Inc., Amgen Inc., Biocon Ltd., Biogen Inc., Boehringer Ingelheim International GmbH, Celltrion Healthcare Co. Ltd., DR Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., Fresenius SE and Co. KGaA, Gedeon Richter PLC, Halozyme Therapeutics Inc., Intas Pharmaceuticals Ltd., Mabion S.A., Novartis AG, Pfizer Inc., Samsung Biologics Co. Ltd., Sanofi SA, Teva Pharmaceutical Industries Ltd., and Viatris Inc.. Also, the biosimilars market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Product Code: IRTNTR70710

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Product Type
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Manufacturing Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
2.3 Factors of disruption
- Overview on factors of disruption
2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029

3 Market Landscape

3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
3.2 Market characteristics
- Market characteristics analysis
3.3 Value chain analysis
- Value chain analysis

4 Market Sizing

4.1 Market definition
- Offerings of companies included in the market definition
4.2 Market segment analysis
- Market segments
4.3 Market size 2024
4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)

5 Historic Market Size

5.1 Global Biosimilars Market 2019 - 2023
- Historic Market Size - Data Table on Global Biosimilars Market 2019 - 2023 ($ million)
5.2 Product Type segment analysis 2019 - 2023
- Historic Market Size - Product Type Segment 2019 - 2023 ($ million)
5.3 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
5.4 Manufacturing Type segment analysis 2019 - 2023
- Historic Market Size - Manufacturing Type Segment 2019 - 2023 ($ million)
5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)

6 Qualitative Analysis

6.1 AI Impact on Global Biosimilars Market

7 Five Forces Analysis

7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029

8 Market Segmentation by Product Type

8.1 Market segments
- Chart on Product Type - Market share 2024-2029 (%)
- Data Table on Product Type - Market share 2024-2029 (%)
8.2 Comparison by Product Type
- Chart on Comparison by Product Type
- Data Table on Comparison by Product Type
8.3 Monoclonal antibodies - Market size and forecast 2024-2029
- Chart on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
- Data Table on Monoclonal antibodies - Market size and forecast 2024-2029 ($ million)
- Chart on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
- Data Table on Monoclonal antibodies - Year-over-year growth 2024-2029 (%)
8.4 Insulin - Market size and forecast 2024-2029
- Chart on Insulin - Market size and forecast 2024-2029 ($ million)
- Data Table on Insulin - Market size and forecast 2024-2029 ($ million)
- Chart on Insulin - Year-over-year growth 2024-2029 (%)
- Data Table on Insulin - Year-over-year growth 2024-2029 (%)
8.5 Human growth hormone - Market size and forecast 2024-2029
- Chart on Human growth hormone - Market size and forecast 2024-2029 ($ million)
- Data Table on Human growth hormone - Market size and forecast 2024-2029 ($ million)
- Chart on Human growth hormone - Year-over-year growth 2024-2029 (%)
- Data Table on Human growth hormone - Year-over-year growth 2024-2029 (%)
8.6 Others - Market size and forecast 2024-2029
- Chart on Others - Market size and forecast 2024-2029 ($ million)
- Data Table on Others - Market size and forecast 2024-2029 ($ million)
- Chart on Others - Year-over-year growth 2024-2029 (%)
- Data Table on Others - Year-over-year growth 2024-2029 (%)
8.7 Market opportunity by Product Type
- Market opportunity by Product Type ($ million)
- Data Table on Market opportunity by Product Type ($ million)

9 Market Segmentation by Application

9.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
9.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
9.3 Oncology and hematology - Market size and forecast 2024-2029
- Chart on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology and hematology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology and hematology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology and hematology - Year-over-year growth 2024-2029 (%)
9.4 Endocrinology - Market size and forecast 2024-2029
- Chart on Endocrinology - Market size and forecast 2024-2029 ($ million)
- Data Table on Endocrinology - Market size and forecast 2024-2029 ($ million)
- Chart on Endocrinology - Year-over-year growth 2024-2029 (%)
- Data Table on Endocrinology - Year-over-year growth 2024-2029 (%)
9.5 Immunology - Market size and forecast 2024-2029
- Chart on Immunology - Market size and forecast 2024-2029 ($ million)
- Data Table on Immunology - Market size and forecast 2024-2029 ($ million)
- Chart on Immunology - Year-over-year growth 2024-2029 (%)
- Data Table on Immunology - Year-over-year growth 2024-2029 (%)
9.6 Nephrology - Market size and forecast 2024-2029
- Chart on Nephrology - Market size and forecast 2024-2029 ($ million)
- Data Table on Nephrology - Market size and forecast 2024-2029 ($ million)
- Chart on Nephrology - Year-over-year growth 2024-2029 (%)
- Data Table on Nephrology - Year-over-year growth 2024-2029 (%)
9.7 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)

10 Market Segmentation by Manufacturing Type

10.1 Market segments
- Chart on Manufacturing Type - Market share 2024-2029 (%)
- Data Table on Manufacturing Type - Market share 2024-2029 (%)
10.2 Comparison by Manufacturing Type
- Chart on Comparison by Manufacturing Type
- Data Table on Comparison by Manufacturing Type
10.3 In-house manufacturing - Market size and forecast 2024-2029
- Chart on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
- Data Table on In-house manufacturing - Market size and forecast 2024-2029 ($ million)
- Chart on In-house manufacturing - Year-over-year growth 2024-2029 (%)
- Data Table on In-house manufacturing - Year-over-year growth 2024-2029 (%)
10.4 Contract manufacturing - Market size and forecast 2024-2029
- Chart on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
- Data Table on Contract manufacturing - Market size and forecast 2024-2029 ($ million)
- Chart on Contract manufacturing - Year-over-year growth 2024-2029 (%)
- Data Table on Contract manufacturing - Year-over-year growth 2024-2029 (%)
10.5 Market opportunity by Manufacturing Type
- Market opportunity by Manufacturing Type ($ million)
- Data Table on Market opportunity by Manufacturing Type ($ million)

11 Customer Landscape

11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

12 Geographic Landscape

12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
12.3 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
12.4 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
12.7 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
12.8 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
12.10 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
12.11 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
12.12 South Korea - Market size and forecast 2024-2029
- Chart on South Korea - Market size and forecast 2024-2029 ($ million)
- Data Table on South Korea - Market size and forecast 2024-2029 ($ million)
- Chart on South Korea - Year-over-year growth 2024-2029 (%)
- Data Table on South Korea - Year-over-year growth 2024-2029 (%)
12.13 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
12.14 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
12.15 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
12.16 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

13 Drivers, Challenges, and Opportunity/Restraints

13.1 Market drivers
13.2 Market challenges
13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
13.4 Market opportunities/restraints

14 Competitive Landscape

14.1 Overview
14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
14.3 Landscape disruption
- Overview on factors of disruption
14.4 Industry risks
- Impact of key risks on business

15 Competitive Analysis

15.1 Companies profiled
- Companies covered
15.2 Company ranking index
- Company ranking index
15.3 Market positioning of companies
- Matrix on companies position and classification
15.4 AbbVie Inc.
- AbbVie Inc. - Overview
- AbbVie Inc. - Product / Service
- AbbVie Inc. - Key news
- AbbVie Inc. - Key offerings
- SWOT
15.5 Amgen Inc.
- Amgen Inc. - Overview
- Amgen Inc. - Product / Service
- Amgen Inc. - Key news
- Amgen Inc. - Key offerings
- SWOT
15.6 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
- SWOT
15.7 Biogen Inc.
- Biogen Inc. - Overview
- Biogen Inc. - Product / Service
- Biogen Inc. - Key news
- Biogen Inc. - Key offerings
- SWOT
15.8 Boehringer Ingelheim International GmbH
- Boehringer Ingelheim International GmbH - Overview
- Boehringer Ingelheim International GmbH - Product / Service
- Boehringer Ingelheim International GmbH - Key news
- Boehringer Ingelheim International GmbH - Key offerings
- SWOT
15.9 Celltrion Healthcare Co. Ltd.
- Celltrion Healthcare Co. Ltd. - Overview
- Celltrion Healthcare Co. Ltd. - Business segments
- Celltrion Healthcare Co. Ltd. - Key offerings
- Celltrion Healthcare Co. Ltd. - Segment focus
- SWOT
15.10 Dr Reddys Laboratories Ltd.
- Dr Reddys Laboratories Ltd. - Overview
- Dr Reddys Laboratories Ltd. - Business segments
- Dr Reddys Laboratories Ltd. - Key news
- Dr Reddys Laboratories Ltd. - Key offerings
- Dr Reddys Laboratories Ltd. - Segment focus
- SWOT
15.11 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
15.12 Fresenius SE and Co. KGaA
- Fresenius SE and Co. KGaA - Overview
- Fresenius SE and Co. KGaA - Business segments
- Fresenius SE and Co. KGaA - Key news
- Fresenius SE and Co. KGaA - Key offerings
- Fresenius SE and Co. KGaA - Segment focus
- SWOT
15.13 Gedeon Richter Plc
- Gedeon Richter Plc - Overview
- Gedeon Richter Plc - Business segments
- Gedeon Richter Plc - Key offerings
- Gedeon Richter Plc - Segment focus
- SWOT
15.14 Halozyme Therapeutics Inc.
- Halozyme Therapeutics Inc. - Overview
- Halozyme Therapeutics Inc. - Product / Service
- Halozyme Therapeutics Inc. - Key offerings
- SWOT
15.15 Intas Pharmaceuticals Ltd.
- Intas Pharmaceuticals Ltd. - Overview
- Intas Pharmaceuticals Ltd. - Product / Service
- Intas Pharmaceuticals Ltd. - Key offerings
- SWOT
15.16 Mabion S.A.
- Mabion S.A. - Overview
- Mabion S.A. - Product / Service
- Mabion S.A. - Key offerings
- SWOT
15.17 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
15.18 Viatris Inc.
- Viatris Inc. - Overview
- Viatris Inc. - Business segments
- Viatris Inc. - Key news
- Viatris Inc. - Key offerings
- Viatris Inc. - Segment focus
- SWOT

16 Appendix

16.1 Scope of the report
16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
16.3 Currency conversion rates for US$
- Currency conversion rates for US$
16.4 Research methodology
- Research methodology
16.5 Data procurement
- Information sources
16.6 Data validation
- Data validation
16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
16.8 Data synthesis
- Data synthesis
16.9 360 degree market analysis
- 360 degree market analysis
16.10 List of abbreviations
- List of abbreviations